XML 27 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Unaudited Interim Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Operating Activities    
Net earnings (loss) $ 184 $ 259
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities    
Asset impairments 0 0
Depreciation, amortization and accretion 72 74
Pension and postretirement net periodic benefit cost (20) (13)
Pension and postretirement contributions (11) (14)
Deferred income taxes, net 14 (2)
(Gain) loss on disposition of businesses and assets, net 1 0
Stock-based compensation 10 10
Undistributed earnings in unconsolidated affiliates 3 (1)
Other, net 2 4
Operating cash provided by (used in) discontinued operations (1) (1)
Changes in operating assets and liabilities    
Trade receivables - third party and affiliates, net (79) (111)
Inventories 9 29
Other assets 21 40
Trade payables - third party and affiliates 6 (8)
Other liabilities (19) 21
Net cash provided by (used in) operating activities 192 287
Investing Activities    
Capital expenditures on property, plant and equipment (62) (70)
Acquisitions, net of cash acquired 0 0
Proceeds from sale of businesses and assets, net 1 0
Other, net (3) (5)
Net cash provided by (used in) investing activities (64) (75)
Financing Activities    
Net change in short-term borrowings with maturities of 3 months or less 6 (344)
Proceeds from short-term borrowings 7 8
Repayments of short-term borrowings (29) (63)
Proceeds from long-term debt 0 170
Repayments of long-term debt (53) (177)
Purchases of treasury stock, including related fees (128) 0
Stock option exercises 0 1
Series A common stock dividends (51) (44)
(Distributions to) contributions from noncontrolling interests (4) 0
Other, net (18) (24)
Net cash provided by (used in) financing activities (270) (473)
Exchange rate effects on cash and cash equivalents 5 10
Net increase (decrease) in cash and cash equivalents (137) (251)
Cash and cash equivalents as of beginning of period 638 967
Cash and cash equivalents as of end of period $ 501 $ 716